✦ LIBER ✦

High dose ascorbate supplementation fails to affect plasma homocyst(e)ine levels in patients with coronary heart disease

✍ Scribed by Andrew G. Bostom; Lisa Yanek; Anne L. Hume; Charles B. Eaton; William McQuade; Marie Nadeau; Gayle Perrone; Paul F. Jacques; Jacob Selhub

Book ID: 118324613
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 325 KB
Volume: 111
Category: Article
ISSN: 0021-9150
DOI: 10.1016/0021-9150(94)90101-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P42 Homocyst(e)ine and fibrinolytic resp

P42 Homocyst(e)ine and fibrinolytic response to standardized venous occlusion in patients with premature coronary heart disease

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 103 KB

EFFECT OF STATIN THERAPY ON PLASMA HIGH-

EFFECT OF STATIN THERAPY ON PLASMA HIGH-DENSITY LIPOPROTEIN–CHOLESTEROL LEVELS IS MODIFIED BY PARAOXONASE 1 IN CHINESE PATIENTS WITH CORONARY HEART DISEASE

✍ Ran Fu; Yan-Ming Sun; Ying Su; Yun Wu; Ying Luan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Ezetimibe added to atorvastatin compared

Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither

✍ S. Conard; H. Bays; L. A. Leiter; S. Bird; J. Lin; M. E. Hanson; A. Shah; A. M. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Relation of Clinical Benefit of Raising

Relation of Clinical Benefit of Raising High-Density Lipoprotein Cholesterol to Serum Levels of Low-Density Lipoprotein Cholesterol in Patients With Coronary Heart Disease (from the Bezafibrate Infarction Prevention Trial)

✍ Ilan Goldenberg; Michal Benderly; Roy Sidi; Valentina Boyko; Alexander Tenenbaum 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 385 KB